Lee, P. C. H., Gu, Y., Yeung, M. Y., Fong, C. H. Y., Woo, Y. C., Chow, W. S., . . . Lam, K. S. L. (2018). Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfunction Among Chinese Subjects with Diabetes in Part Through Glycemic Improvement: A Single-Center, Retrospective, Observational Study. Diabetes Ther.
Citação norma ChicagoLee, Paul Chi Ho, Yunjuan Gu, Man Yi Yeung, Carol Ho Yi Fong, Yu Cho Woo, Wing Sun Chow, Kathryn Tan, and Karen Siu Ling Lam. "Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfunction Among Chinese Subjects With Diabetes in Part Through Glycemic Improvement: A Single-Center, Retrospective, Observational Study." Diabetes Ther 2018.
MLA citiranjeLee, Paul Chi Ho, et al. "Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfunction Among Chinese Subjects With Diabetes in Part Through Glycemic Improvement: A Single-Center, Retrospective, Observational Study." Diabetes Ther 2018.